2022
DOI: 10.3390/biom12060742
|View full text |Cite
|
Sign up to set email alerts
|

Gadolinium in Medical Imaging—Usefulness, Toxic Reactions and Possible Countermeasures—A Review

Abstract: Gadolinium (Gd) is one of the rare-earth elements. The properties of its trivalent cation (Gd3+) make it suitable to serve as the central ion in chelates administered intravenously to patients as a contrast agent in magnetic resonance imaging. Such Gd-chelates have been used for more than thirty years. During the past decades, knowledge has increased about potential harmful effects of Gd-chelates in patients with severe renal dysfunction. In such patients, there is a risk for a potentially disabling and lethal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
18
0
5

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(23 citation statements)
references
References 55 publications
0
18
0
5
Order By: Relevance
“…1 Nevertheless, during the past decades, warnings about potential harmful effects from the use of linear GBCAs ascribable to the release of free gadolinium cations have been raised. 30,31 In particular, there are findings proving that multiple administrations of linear GBCAs, are responsible for a far higher retention of gadolinium in the brain of healthy patients with respect to macrocyclic ones. [32][33][34] Although the risk of adverse effects due to gadolinium deposition was not proven, in 2017 the European Medicines Agency's recommended the removal of linear GBCAs from the market, 35 while, in the same year, the US Food and Drug Administration announced that they would not restrict the use of linear GBCAs and suggested that the type of GBCA used should be carefully selected in highrisk patients (pregnant women, children, and patients with inflammatory conditions).…”
Section: Discussionmentioning
confidence: 99%
“…1 Nevertheless, during the past decades, warnings about potential harmful effects from the use of linear GBCAs ascribable to the release of free gadolinium cations have been raised. 30,31 In particular, there are findings proving that multiple administrations of linear GBCAs, are responsible for a far higher retention of gadolinium in the brain of healthy patients with respect to macrocyclic ones. [32][33][34] Although the risk of adverse effects due to gadolinium deposition was not proven, in 2017 the European Medicines Agency's recommended the removal of linear GBCAs from the market, 35 while, in the same year, the US Food and Drug Administration announced that they would not restrict the use of linear GBCAs and suggested that the type of GBCA used should be carefully selected in highrisk patients (pregnant women, children, and patients with inflammatory conditions).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, the medical imaging procedure must be undertaken with strict adherence to the laid down policies and effective equipment to minimize the risk to the patient and the fetus. This defines the principles followed by physicians and radiologists when making decisions regarding imaging procedures [ 27 ]. Educating the patient about the importance of the imaging procedure and obtaining consent is important in communicating with the patient about the risks and benefits of the imaging procedure.…”
Section: Reviewmentioning
confidence: 99%
“…It is worth noting that the coordinated heavy metallic ions that donate PBAs with advanced imaging functionalities (MRI and PET) probably can bring toxicity for PBAs. For example, studies have demonstrated that Gd 3+ could accumulate inside the brain and cause kidney damage. , As a result, in-depth investigation on the biosafety of PBAs is necessary for in vivo application.…”
Section: Biomedical Applicationsmentioning
confidence: 99%
“…For example, studies have demonstrated that Gd 3+ could accumulate inside the brain and cause kidney damage. 192,193 As a result, in-depth investigation on the biosafety of PBAs is necessary for in vivo application.…”
Section: 12 Magnetic Resonance Imaging (Mri) and Positron Emission To...mentioning
confidence: 99%